The objective of this research is to devise safe and efficient targeted synthetic gene vectors for parenteral administration in animals. The dogma guiding our plan is that processes and molecular strategies employed by viruses in the infection process can be recapitulated in less complicated molecules. When these simpler molecules are correctly assembled with plasmid DNA in a nanolipoparticle (NLP), an efficient gene delivery system will be created. There are three major activities in the program: (a) synthesis of novel components, (b) assembly of the components into a small diameter, stable particle and (c) characterization of the performance of the assembled components in cells and animals. The plan is organized to accomplish four specific aims that are based upon testable hypotheses that are fully articulated in the application.
Specific aim (1): To devise lipids that change structure either at low pH or under reducing conditions, that can be employed to package the DNA in a NLP, assist delivery in vivo and mediate rapid, efficient cytoplasmic entry after internalization into cells.
Specific aim (2): To devise processes and techniques to assemble the components required for efficient gene transfer into a stable NLP with a diameter <100 nm.
Specific aim (3): To create a macromolecular motor that can be attached to DNA and mediate transport of the DNA along microtubules toward the nucleus.
Specific aim (4): To characterize the safety and gene transfer efficiency of targeted NLPs in cells and animals. Two targets will be investigated: (1) targeting with epidermal growth factor to hepatocytes in normal liver after tail vein administration of a low volume formulation. (2) targeting with an oligosaccharide from hyaluronan to CD44 expressing tumors in mice. Completion of these specific aims will lead to a targeted, biodegradable synthetic gene vector with an in vivo gene transfer efficiency approaching that of current viral vectors but with a better safety profile. This improved gene carrier will enable successful gene therapy for a variety of currently untreatable genetic and neoplastic diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
1R01EB003008-01
Application #
6736576
Study Section
Special Emphasis Panel (ZRG1-SSS-2 (55))
Program Officer
Moy, Peter
Project Start
2003-09-22
Project End
2008-07-31
Budget Start
2003-09-22
Budget End
2004-07-31
Support Year
1
Fiscal Year
2003
Total Cost
$375,400
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Tiffany, Matthew; Szoka, Francis C (2016) Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios. J Drug Target 24:857-864
Kierstead, Paul H; Okochi, Hideaki; Venditto, Vincent J et al. (2015) The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes. J Control Release 213:1-9
Nguyen, Juliane; Sievers, Richard; Motion, J P Michael et al. (2015) Delivery of lipid micelles into infarcted myocardium using a lipid-linked matrix metalloproteinase targeting peptide. Mol Pharm 12:1150-7
Guo, Xin; Gagne, Lucie; Chen, Haigang et al. (2014) Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo. J Liposome Res 24:90-8
Venditto, Vincent J; Dolor, Aaron; Kohli, Aditya et al. (2014) Sulfated quaternary amine lipids: a new class of inverse charge zwitterlipids. Chem Commun (Camb) 50:9109-11
Kohli, Aditya G; Kierstead, Paul H; Venditto, Vincent J et al. (2014) Designer lipids for drug delivery: from heads to tails. J Control Release 190:274-87
Venditto, Vincent J; Szoka Jr, Francis C (2013) Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliv Rev 65:80-8
Walsh, Colin L; Nguyen, Juliane; Tiffany, Matthew R et al. (2013) Synthesis, characterization, and evaluation of ionizable lysine-based lipids for siRNA delivery. Bioconjug Chem 24:36-43
Sockolosky, Jonathan T; Szoka, Francis C (2013) Periplasmic production via the pET expression system of soluble, bioactive human growth hormone. Protein Expr Purif 87:129-35
Motion, J P Michael; Nguyen, Juliane; Szoka, Francis C (2012) Phosphatase-triggered fusogenic liposomes for cytoplasmic delivery of cell-impermeable compounds. Angew Chem Int Ed Engl 51:9047-51

Showing the most recent 10 out of 30 publications